CD140b, Human (Rinucumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD140b, Human (Rinucumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD140b, Human (Rinucumab biosimilar)
CloneRinucumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG4 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD140b Recombinant Antibody. Rinucumab (REGN2176) is a monoclonal antibody designed for the treatment of neovascular age-related macular degeneration.[ This drug was developed by Regeneron Pharmaceuticals, Inc.
Immunogenn/a
Other NamesAnti-CD140b Recombinant Antibody, Research Grade Rinucumab, Anti-Human CD140b Recombinant Antibody, REGN-2176, REGN-2176-3 (combination of aflibercept and ricunumab), REGN2176, Antibody Drug Analogues, Monoclonal Antibody, YR1389, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1569263-06-4
Catalog #YR1389
Priceplease inquire
Order / More InfoCD140b, Human (Rinucumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.